Catheter Precision, Inc. (VTAK) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
21/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseVTAK / S&P -15.84% / 15.20% |
WinVTAK / S&P 219.17% / 15.00% |
LoseVTAK / S&P VTAK unavailable / 50.40% |
| 2026-Q11/3 |
LoseVTAK / S&P -44.81% / -4.33% |
WinVTAK / S&P 130.35% / 11.30% |
LoseVTAK / S&P VTAK unavailable / 27.70% |
| 2025-Q41/3 |
LoseVTAK / S&P -27.38% / 2.65% |
WinVTAK / S&P 95.00% / 9.00% |
LoseVTAK / S&P VTAK unavailable / 13.40% |
| 2025-Q31/3 |
LoseVTAK / S&P -44.74% / 8.12% |
WinVTAK / S&P 82.96% / 4.61% |
LoseVTAK / S&P VTAK unavailable / 13.45% |
| 2025-Q21/3 |
LoseVTAK / S&P -29.41% / 10.94% |
WinVTAK / S&P 37.61% / 4.83% |
LoseVTAK / S&P VTAK unavailable / 10.63% |
| 2025-Q11/3 |
LoseVTAK / S&P -24.44% / -4.27% |
WinVTAK / S&P 9.57% / 4.98% |
LoseVTAK / S&P VTAK unavailable / 10.57% |
| 2024-Q41/3 |
WinVTAK / S&P 12.50% / 2.41% |
LoseVTAK / S&P -4.98% / 5.25% |
LoseVTAK / S&P VTAK unavailable / 6.15% |
| 2024-Q31/3 |
LoseVTAK / S&P -93.22% / 5.89% |
WinVTAK / S&P 27.07% / 5.89% |
LoseVTAK / S&P VTAK unavailable / 6.11% |
| 2024-Q22/3 |
WinVTAK / S&P 20.41% / 4.28% |
WinVTAK / S&P 140.88% / 5.38% |
LoseVTAK / S&P VTAK unavailable / 5.12% |
| 2024-Q12/3 |
WinVTAK / S&P 22.50% / 10.56% |
WinVTAK / S&P 387.78% / 5.71% |
LoseVTAK / S&P VTAK unavailable / 5.59% |
| 2023-Q41/3 |
LoseVTAK / S&P -9.09% / 11.69% |
WinVTAK / S&P 3057.14% / 6.81% |
LoseVTAK / S&P VTAK unavailable / 7.78% |
| 2023-Q31/3 |
LoseVTAK / S&P -52.17% / -3.27% |
WinVTAK / S&P 1552.63% / 7.52% |
LoseVTAK / S&P VTAK unavailable / -5.03% |
| 2023-Q21/3 |
LoseVTAK / S&P -39.87% / 8.74% |
WinVTAK / S&P 654.17% / 9.50% |
LoseVTAK / S&P VTAK unavailable / -8.57% |
| 2023-Q11/3 |
LoseVTAK / S&P -74.02% / 7.50% |
WinVTAK / S&P 221.43% / 10.77% |
LoseVTAK / S&P VTAK unavailable / -15.69% |
| 2022-Q40/3 |
LoseVTAK / S&P -1.83% / 7.56% |
LoseVTAK / S&P -39.13% / 11.88% |
LoseVTAK / S&P VTAK unavailable / -17.99% |
| 2022-Q30/3 |
LoseVTAK / S&P -61.29% / -4.88% |
LoseVTAK / S&P 5.56% / 13.47% |
LoseVTAK / S&P VTAK unavailable / -1.41% |
| 2022-Q20/3 |
LoseVTAK / S&P -22.50% / -16.10% |
LoseVTAK / S&P -70.37% / 13.71% |
LoseVTAK / S&P VTAK unavailable / 11.04% |
| 2022-Q10/3 |
LoseVTAK / S&P -74.36% / -4.60% |
LoseVTAK / S&P -97.12% / 15.97% |
LoseVTAK / S&P VTAK unavailable / 42.23% |
| 2021-Q40/3 |
LoseVTAK / S&P -50.32% / 11.03% |
LoseVTAK / S&P -99.02% / 15.00% |
LoseVTAK / S&P VTAK unavailable / 96.40% |
| 2021-Q30/3 |
LoseVTAK / S&P -28.15% / 0.58% |
LoseVTAK / S&P -99.52% / 10.77% |
LoseVTAK / S&P VTAK unavailable / 69.42% |
| 2021-Q20/3 |
LoseVTAK / S&P -6.22% / 8.55% |
LoseVTAK / S&P -98.55% / 6.58% |
LoseVTAK / S&P VTAK unavailable / 51.81% |
| 2021-Q10/3 |
LoseVTAK / S&P -37.28% / 6.17% |
LoseVTAK / S&P -85.76% / -1.06% |
LoseVTAK / S&P VTAK unavailable / 7.39% |
| 2020-Q40/3 |
LoseVTAK / S&P 2.48% / 12.15% |
LoseVTAK / S&P -67.47% / -3.72% |
LoseVTAK / S&P VTAK unavailable / -33.42% |
| 2020-Q30/3 |
LoseVTAK / S&P -40.82% / 8.93% |
LoseVTAK / S&P -52.14% / -2.04% |
LoseVTAK / S&P VTAK unavailable / -27.10% |
| 2020-Q20/3 |
LoseVTAK / S&P -55.05% / 20.54% |
LoseVTAK / S&P -29.94% / -0.46% |
LoseVTAK / S&P VTAK unavailable / -27.11% |
| 2020-Q11/3 |
WinVTAK / S&P -3.54% / -19.60% |
LoseVTAK / S&P -3.00% / 3.47% |
LoseVTAK / S&P VTAK unavailable / -14.75% |
| 2019-Q41/3 |
LoseVTAK / S&P -19.29% / 9.07% |
WinVTAK / S&P 15.06% / 5.36% |
LoseVTAK / S&P VTAK unavailable / 2.99% |
| 2019-Q31/3 |
LoseVTAK / S&P -61.33% / 1.70% |
WinVTAK / S&P 25.64% / 5.02% |
LoseVTAK / S&P VTAK unavailable / 0.21% |
| 2019-Q22/3 |
WinVTAK / S&P 6.47% / 4.30% |
WinVTAK / S&P 46.38% / 6.64% |
LoseVTAK / S&P VTAK unavailable / 8.65% |
| 2019-Q10/3 |
LoseVTAK / S&P -57.23% / 13.65% |
LoseVTAK / S&P VTAK unavailable / 8.12% |
LoseVTAK / S&P VTAK unavailable / 14.29% |
| 2018-Q40/3 |
LoseVTAK / S&P -56.32% / -13.52% |
LoseVTAK / S&P VTAK unavailable / 9.05% |
LoseVTAK / S&P VTAK unavailable / 18.23% |
| 2018-Q30/3 |
LoseVTAK / S&P VTAK unavailable / 7.71% |
LoseVTAK / S&P VTAK unavailable / 10.21% |
LoseVTAK / S&P VTAK unavailable / 19.06% |
| 2018-Q20/3 |
LoseVTAK / S&P VTAK unavailable / 3.43% |
LoseVTAK / S&P VTAK unavailable / 9.03% |
LoseVTAK / S&P VTAK unavailable / 14.46% |
| 2018-Q10/3 |
LoseVTAK / S&P VTAK unavailable / -0.76% |
LoseVTAK / S&P VTAK unavailable / 7.68% |
LoseVTAK / S&P VTAK unavailable / 12.46% |
| 2017-Q40/3 |
LoseVTAK / S&P VTAK unavailable / 6.64% |
LoseVTAK / S&P VTAK unavailable / 7.03% |
LoseVTAK / S&P VTAK unavailable / 13.82% |
| 2017-Q30/3 |
LoseVTAK / S&P VTAK unavailable / 4.48% |
LoseVTAK / S&P VTAK unavailable / 5.68% |
LoseVTAK / S&P VTAK unavailable / 17.57% |
| 2017-Q20/3 |
LoseVTAK / S&P VTAK unavailable / 3.09% |
LoseVTAK / S&P VTAK unavailable / 4.83% |
LoseVTAK / S&P VTAK unavailable / 17.74% |
| 2017-Q10/3 |
LoseVTAK / S&P VTAK unavailable / 6.07% |
LoseVTAK / S&P VTAK unavailable / 3.67% |
LoseVTAK / S&P VTAK unavailable / 13.32% |
| 2016-Q40/3 |
LoseVTAK / S&P VTAK unavailable / 3.82% |
LoseVTAK / S&P VTAK unavailable / 2.09% |
LoseVTAK / S&P VTAK unavailable / 7.05% |
| 2016-Q30/3 |
LoseVTAK / S&P VTAK unavailable / 3.85% |
LoseVTAK / S&P VTAK unavailable / 0.20% |
LoseVTAK / S&P VTAK unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | VTAK total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -92.00% | 20.78% |
| Annualized return | -92.00% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | VTAK total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 83.14% |
| Annualized return | -90.77% | 12.86% |
10Y · 2018-09-27 to 2026-08-27
| Metric | VTAK total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 319.30% |
| Annualized return | -81.70% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |